(Press-News.org) New Haven, Conn. — While pembrolizumab is an approved treatment for patients with stage III non-small cell lung cancer (NSCLC), only some patients respond to this therapy. Treatment failure, researchers say, is often caused by differences in the tumor microenvironment. An ongoing phase II study (KEYNOTE-495/KeyImPaCT) led by a researcher at Yale Cancer Center reveals that combining pembrolizumab with other treatments reduced the size of target tumors, resulting in a higher response rate for patients with advanced NSCLC.
The new research was published July 10 in Nature Medicine.
“We are excited to share these new findings, which show promising results for pembrolizumab-based treatment regimens for patients with advanced NSCLC,” said senior author Roy Herbst, deputy director of Yale Cancer Center and assistant dean for translational research at Yale School of Medicine. “We are very pleased with how the treatment regimens helped improve survival outcomes for patients.”
In this study, patients were categorized into four biomarker-defined groups based on their gene expression and amount of gene mutation in the cancer cells. Essentially, patients were grouped by similar tumor microenvironment. Patients in each of the four groups were then randomly assigned to receive pembrolizumab (also marketed under the name Keytruda) in combination with one of three other cancer treatments: lenvatinib (also known as Lenvima), quavonlimab, or favezelimab.
“The study's approach of categorizing patients into biomarker-defined subgroups allows us to identify potential unique resistance mechanisms and tailor treatment strategies accordingly,” said Herbst.
The study assessed the objective response rate (ORR), or the percentage of patients who had a partial or complete response to the treatment, as well as progression-free survival (PFS), and safety.
The study reported ORR ranges of 0% to 12% in group I, 27.3% to 33.3% in group II, 13.6% to 40.9% in group III, and 50% to 60% in group IV, with ranges encompassing the results of the different treatment combinations. There was at least a 30% reduction in the target tumor size in more than 58% of patients in group IV. PFS was also highest for group IV, ranging from 6.3 months to 17.8 months. The most common treatment-related adverse events included hypertension, itchy skin, and fatigue.
The interim results from the study showed that each of the treatment combinations provided anti-tumor activity, particularly in group IV. Additional research from the trial will provide further insight on optimal combinations targeting specific molecular subtypes in NSCLC and other tumor types.
“These findings reinforce the importance of personalized medicine in improving outcomes for patients with NSCLC and pave the way for further advancements in pembrolizumab combination therapies,” said Herbst.
The first author was Dr. Martin Gutierrez at Hackensack University Medical Center. Funding for this research was provided by Merck Sharp & Dohme, LLC, a subsidiary of Merck.
END
Combination cancer therapies can shrink tumors and improve survival outcomes for patients with advanced non-small lung cancer
2023-07-13
ELSE PRESS RELEASES FROM THIS DATE:
NSF CAREER award invests in the future of stable computing
2023-07-12
Every night, uncounted numbers of devices across the globe update their operating systems (OS), and everyday users log on expecting fast, secure connections and services to keep their increasingly online lives moving forward. But as artificial intelligence and other more complex systems come online, the foundation of all them is teetering.
Every aspect of society — from government and industry to education and entertainment — relies on devices with stable operating systems. And every OS relies on ...
Collaborative seed grants nurture high-impact social and environmental research
2023-07-12
The National Science Foundation, the National Institutes of Health, and the National Aeronautics and Space Administration have collectively awarded millions of dollars in grant funding to numerous Virginia Tech researchers who all have one thing in common.
They were awarded Emerging Social Aspects of Global Change seed funding.
Since 2015, this funding has led to faculty from seven colleges and 15 departments collaborating and engaging in 10 research projects that address the social or policy aspects of major global environmental issues.
Sponsored by Fralin Life Sciences Institute’s Global Change Center and the Institute ...
The picture of health: Virginia Tech researchers enhance bioimaging and sensing with quantum photonics
2023-07-12
Imagine you just swallowed a pill containing a miniature camera that will help your doctor collect images to diagnose a condition you’ve been battling for years. No, it’s not something from the latest science fiction or Marvel Comics movie – it’s a technique called bioimaging.
While traditional methods of bioimaging such as an MRI, CT scan, or an X-ray are more commonly known, the use of nanodevices is becoming more popular. They are less invasive and provide health care professionals with a closer look deep inside tissue.
Researchers from Virginia Tech’s College of Engineering and College of Science are using their expertise ...
Virginia Tech awarded $3.4 million grant to study the environmental effects of utility-scale solar installations
2023-07-12
As utility-scale solar farms become more widespread as a source of renewable energy, Virginia Tech scientists are researching environmental consequences with respect to stormwater and the sediment and nutrients transported in runoff.
With a $3.4 million grant from the Virginia Department of Environmental Quality, researchers from the College of Agriculture and Life Sciences will lead a comprehensive six-year study to determine how utility-scale solar farms impact stormwater runoff and local soil and water quality throughout the state.
“Solar is probably going to be the No. 1 land use change that will occur over the next decade in many parts of Virginia, particularly in existing ...
Rare brain tumor responds to targeted tumor treatment with ‘unprecedented’ success
2023-07-12
Papillary craniopharyngiomas (PCPs) are a rare type of brain tumor that cause substantial morbidity for patients. While surgery and radiation are often used to treat PCPs, incomplete removal of the tumor and toxicity from radiation can leave patients with life-long health challenges after treatment, including neuroendocrine dysfunction or vision or memory loss. Investigators from the Mass General Cancer Center, a member of the Mass General Brigham healthcare system, led the first multicenter treatment protocol in this rare tumor. The study was based on laboratory discoveries by Mass General Brigham researchers who studied the genetic drivers of PCP growth, ...
Salinity changes threatening marine ecosystems, new UNF study shows
2023-07-12
A groundbreaking study published today reveals the critical yet severely understudied factor of salinity changes in ocean and coastlines caused by climate change. The study was co-authored by an international team of researchers, including Dr. Cliff Ross, University of North Florida biology chair/professor, and Dr. Stacey Trevathan-Tackett, UNF biology graduate program alum and research faculty member at Deakin University in Australia.
Changes in salinity, or salt content, due to climate change and land use can have potentially devastating impacts on vital coastal and estuarine ecosystems, yet this has rarely been studied until now. This new research provides valuable ...
Two UTA professors selected as Fulbright scholars
2023-07-12
Two University of Texas at Arlington faculty members have received Fulbright U.S. Scholar Program awards from the U.S. Department of State and the Fulbright Foreign Scholarship Board.
Kevin Schug, Shimadzu Distinguished Professor of Analytical Chemistry in the Department of Chemistry and Biochemistry, will travel to Palacky University in Olomouc, Czech Republic, continuing a decades-long relationship that began during his days as a graduate student.
Ling Xu, associate professor in the School of Social Work, will use the award to travel to Taiwan and embark on 10-month project to raise awareness about the ...
Daughters breastfed longer, and women accumulated greater wealth in ancient California matriarchal society
2023-07-12
In a new study, researchers and members of the Muwekma Ohlone Tribe of the San Francisco Bay Area are the first to publish evidence of wealth-driven patterns in maternal investment among ancient populations.
Ancestors of the Muwekma Ohlone living 2,000 years ago at Kalawwasa Rummeytak in present-day Silicon Valley in California’s San Francisco Bay Area, placed high value on women’s economic contributions to their communities, according to the study. Women stayed in the villages in which they were born, and their male partners moved from their birth communities to join their wives’ families. Women’s intimate knowledge of the local ecology and female ...
Food insecurity rate hits 17% for the second time in 18 months
2023-07-12
Food insecurity rate hits 17% for the second time in 18 months
WEST LAFAYETTE, Ind. – Reported food insecurity has reached 17%, matching the rate last reached in March 2022, according to the June Consumer Food Insights Report. The new report also includes consumer changes in food spending as a result of a hypothetical recession and sentiments on artificial intelligence.
The survey-based report out of Purdue University’s Center for Food Demand Analysis and Sustainabilityassesses food spending, consumer satisfaction ...
Social isolation linked to lower brain volume
2023-07-12
EMBARGOED FOR RELEASE UNTIL 4 P.M. ET, WEDNESDAY, JULY 12, 2023
MINNEAPOLIS – Older people who have little social contact with others may be more likely to have loss of overall brain volume, and in areas of the brain affected by dementia, than people with more frequent social contact, according to a study published in the July 12, 2023, online issue of Neurology®, the medical journal of the American Academy of Neurology.
The study does not prove that social isolation causes brain shrinkage; it only shows an association.
“Social isolation is a growing problem for older ...